ARTICLE | Company News
BioReliance, MediGene in HSV deal
August 15, 2001 7:00 AM UTC
BREL will manufacture for MediGene (NMarkt:MDG) clinical supplies of herpes simplex virus-derived G207 and NV1020 to treat brain tumors and colorectal metastasis to the liver. BREL also will provide t...